Versor Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,857
Closed -$997K 792
2023
Q3
$997K Buy
+1,857
New +$957K 0.2% 109
2020
Q3
Sell
-5,146
Closed -$845K 316
2020
Q2
$845K Buy
+5,146
New +$790K 0.08% 34
2019
Q4
Sell
-10,800
Closed -$1.21M 339
2019
Q3
$1.21M Sell
10,800
-19,600
-64% -$2.18M 0.08% 118
2019
Q2
$3.37M Buy
+30,400
New +$3.58M 0.22% 62

Other funds holding LLY

Versor Investments's LLY Position: Q4 2023 in Review

Versor Investments sold out of Eli Lilly (LLY) in Q4 2023, closing a stake of 1,857 shares — an estimated $997K sold.

Versor Investments first reported a position in LLY in Q2 2019 and held it in 4 quarters. The position peaked at $3.37M in Q2 2019. 3,273 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Versor Investments reported no remaining Eli Lilly position as of Q4 2023 after selling out during the quarter.
  • Versor Investments sold 1,857 Eli Lilly shares in Q4 2023, an estimated $997K.
  • Versor Investments first reported a position in Eli Lilly in Q2 2019 and held it in 4 quarters.
  • Versor Investments's Eli Lilly position peaked at $3.37M in Q2 2019.
  • 3,273 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Versor Investments's 13F filing for Q4 2023, filed 7 Feb 2024.